Brandie Taylor (@bct255) 's Twitter Profile
Brandie Taylor

@bct255

PhD candidate studying tumor immunology/cancer biology in the @balkolab at Vanderbilt University

ID: 1022584776119734274

calendar_today26-07-2018 20:49:44

121 Tweet

222 Followers

232 Following

Brandie Taylor (@bct255) 's Twitter Profile Photo

Happy to share our work just out at JITC! We highlight the potential of targeting EZH2 as a therapeutic strategy to enhance MHC-II expression and improve immunotherapy efficacy. Jamaal L. James BalkoResearchLab

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

Let’s take a closer look at “Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance” by Brandie Taylor BalkoResearchLab at @VUBasicScience Vanderbilt University Medical Center 1/9

Let’s take a closer look at “Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance” by <a href="/BCT255/">Brandie Taylor</a> <a href="/BalkoLab/">BalkoResearchLab</a> at @VUBasicScience <a href="/VUMCDiscoveries/">Vanderbilt University Medical Center</a> 1/9
Kara McNamara (@mcnamara_kara) 's Twitter Profile Photo

Excited to announce our new publication in Scientific Reports examining the role of talin-1 in macrophages during infectious colitis. Special thanks to our collaborators in the Jeremy Goettel lab! We did it Yvonne Latour !!🍾🥳 pubmed.ncbi.nlm.nih.gov/38102166/

Vanderbilt School of Medicine Basic Sciences (@vubasicsciences) 's Twitter Profile Photo

A recent paper from the @balkolab, led by Jamaal James and @bct255, indicates that EZH2 inhibition leads to enhanced MHC-II expression potentially through the improvement of chromatin accessibility at CIITA, the master regulator of MHC-II. doi.org/10.1136/jitc-2…

Vanderbilt Molecular Physiology & Biophysics (@vanderbiltmpb) 's Twitter Profile Photo

Join us in two weeks as Emily Hawes (Emily Hawes), a graduate student in the lab of Richard O'Brien, presents her dissertation work on the "Regulation of Glucose-6-Phosphatase Catalytic Subunit 2 (G6PC2) Expression and Activity!"

Join us in two weeks as Emily Hawes (<a href="/EmilyMHawes/">Emily Hawes</a>), a graduate student in the lab of Richard O'Brien, presents her dissertation work on the "Regulation of Glucose-6-Phosphatase Catalytic Subunit 2 (G6PC2) Expression and Activity!"
Cancer Discovery (@cd_aacr) 's Twitter Profile Photo

From the February issue— #NKG2A is a Therapeutic Vulnerability in #Immunotherapy Resistant MHC-I Heterogeneous Triple Negative #BreastCancer, by Brandie Taylor, Xiaopeng, BalkoResearchLab et al. bit.ly/49CFb4U Vanderbilt University Medical Center #TNBC

From the February issue—
#NKG2A is a Therapeutic Vulnerability in #Immunotherapy Resistant MHC-I Heterogeneous Triple Negative #BreastCancer, by <a href="/BCT255/">Brandie Taylor</a>, <a href="/SXPung/">Xiaopeng</a>, <a href="/BalkoLab/">BalkoResearchLab</a> et al.
bit.ly/49CFb4U
<a href="/VUMCDiscoveries/">Vanderbilt University Medical Center</a> #TNBC
VU Chemical Biology (@vicb_vanderbilt) 's Twitter Profile Photo

Save the date for Vanderbilt Cancer Biology Graduate Program Melissa M Wolf's (Kimryn Rathmell & Jeff Rathmell labs) dissertation defense! “VHL Deficiency and the Tumor Microenvironment in Renal Cell Carcinoma” Friday, March 1st 3:30 PM PRB 898J

Save the date for Vanderbilt Cancer Biology Graduate Program <a href="/melissa_m_wolf/">Melissa M Wolf</a>'s (<a href="/KimrynRathmell/">Kimryn Rathmell</a> &amp; <a href="/JeffRathmell/">Jeff Rathmell</a> labs) dissertation defense! “VHL Deficiency and the Tumor Microenvironment in Renal Cell Carcinoma”

Friday, March 1st
3:30 PM
PRB 898J
AACR (@aacr) 's Twitter Profile Photo

Today is the AACR Early-Career National Day of Action, and we're calling on early-career scientists, trainees, students, and all who support them to contact members of Congress and ask them to prioritize NIH funding. Take action: AACR.org/AACRECHD24 #AACRontheHill #FundNIH

Today is the AACR Early-Career National Day of Action, and we're calling on early-career scientists, trainees, students, and all who support them to contact members of Congress and ask them to prioritize <a href="/NIH/">NIH</a> funding. Take action: AACR.org/AACRECHD24 #AACRontheHill #FundNIH
AACR (@aacr) 's Twitter Profile Photo

We had a very productive 9th Annual Early-Career Hill Day. Our 20 AACR Associate Members are wrapping up their meetings, but you can still take action in support of early-career scientists by visiting bit.ly/48yoSoV. #AACRontheHill #FundNIH

We had a very productive 9th Annual Early-Career Hill Day. Our 20 AACR Associate Members are wrapping up their meetings, but you can still take action in support of early-career scientists by visiting
bit.ly/48yoSoV. #AACRontheHill #FundNIH
Eli Fritz McDonald (@elifritzmcd) 's Twitter Profile Photo

I'm defending next week on March 21st at 11:30 am central time. Stop by to hear about the secrets of CFTR revealed.. DM me for a zoom link Plate Lab and Jens Meiler Lab

I'm defending next week on March 21st at 11:30 am central time.

Stop by to hear about the secrets of CFTR revealed..

DM me for a zoom link

<a href="/Plate_Lab/">Plate Lab</a> and <a href="/MeilerLab/">Jens Meiler Lab</a>
Susan G. Komen (@susangkomen) 's Twitter Profile Photo

Komen grantee BalkoResearchLab presents his work on understanding and improving #breastcancer response to immunotherapy @ #AACR24. To learn more, check out the MBC Impact Series where he discussed his work: bit.ly/4cFtpsN

Komen grantee <a href="/BalkoLab/">BalkoResearchLab</a> presents his work on understanding and improving #breastcancer response to immunotherapy @ #AACR24. To learn more, check out the MBC Impact Series where he discussed his work: bit.ly/4cFtpsN